Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen
This study has been completed.
Study NCT00002429. Last updated on October 1, 2007. Information provided by Bristol-Myers Squibb
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1
Conditions listed in this trial
HIV Infections
2
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
3
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
4
Interventions listed in this trial
Lamivudine/Zidovudine
Nelfinavir mesylate
Stavudine
Didanosine
5
Additional drug interventions recognized in this trial
Nelfinavir
6
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antiviral Agents
Enzyme Inhibitors
HIV Protease Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Protease Inhibitors
Reverse Transcriptase Inhibitors
Therapeutic Uses
7
Sponsors listed in this trial
Bristol-Myers Squibb
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers